These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9786263)
1. Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. Parra JR; Cambria RA; Hower CD; Dassow MS; Freischlag JA; Seabrook GR; Towne JB J Vasc Surg; 1998 Oct; 28(4):669-75. PubMed ID: 9786263 [TBL] [Abstract][Full Text] [Related]
2. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall. Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480 [TBL] [Abstract][Full Text] [Related]
3. Morphologic characteristics of varicose veins: possible role of metalloproteinases. Woodside KJ; Hu M; Burke A; Murakami M; Pounds LL; Killewich LA; Daller JA; Hunter GC J Vasc Surg; 2003 Jul; 38(1):162-9. PubMed ID: 12844106 [TBL] [Abstract][Full Text] [Related]
4. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. Gillespie DL; Patel A; Fileta B; Chang A; Barnes S; Flagg A; Kidwell M; Villavicencio JL; Rich NM J Surg Res; 2002 Aug; 106(2):233-8. PubMed ID: 12175972 [TBL] [Abstract][Full Text] [Related]
5. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407 [TBL] [Abstract][Full Text] [Related]
6. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis. Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524 [TBL] [Abstract][Full Text] [Related]
7. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N Digestion; 1999; 60(3):246-54. PubMed ID: 10343138 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253 [TBL] [Abstract][Full Text] [Related]
10. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation. Naik B; Kumar M; Khanna AK; Suman PK Indian J Pathol Microbiol; 2016; 59(1):25-30. PubMed ID: 26960630 [TBL] [Abstract][Full Text] [Related]
11. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. George SJ; Zaltsman AB; Newby AC Cardiovasc Res; 1997 Feb; 33(2):447-59. PubMed ID: 9074710 [TBL] [Abstract][Full Text] [Related]
12. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis. Gomez DE; De Lorenzo MS; Alonso DF; Andrade ZA Am J Trop Med Hyg; 1999 Jul; 61(1):9-13. PubMed ID: 10432047 [TBL] [Abstract][Full Text] [Related]
13. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566 [TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study]. Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371 [TBL] [Abstract][Full Text] [Related]
15. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture. Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in the vein wall. Kowalewski R; Sobolewski K; Wolanska M; Gacko M Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895 [TBL] [Abstract][Full Text] [Related]
17. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hayashi T; Fleming MV; Stetler-Stevenson WG; Liotta LA; Moss J; Ferrans VJ; Travis WD Hum Pathol; 1997 Sep; 28(9):1071-8. PubMed ID: 9308732 [TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]